Hematological Malignancies Clinical Trials in Amsterdam
2 recruitingAmsterdam, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Janssen Research & Development, LLC510 enrolled78 locationsNCT04634552
Recruiting
Phase 3
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Hematological Malignancies
Galapagos NV546 enrolled6 locationsNCT06652633